insitro

7 statements across 2 episodes · 4 bullish · 0 bearish · 1 people on the record · first statement May 19, 2023 by Daphne Koller · said 13 times in 4 episodes since 2023 · across every show →

Mentions by year

brought up most by Sarah Guo (6), Elad Gil (5), Daphne Koller (1)

tap a year for its mentions
008215320232024episodesmentions
02320232024episodes it came up in
0021.54320232024episodesmentions per episode
2024 1 mention in 1 episode
2023 12 mentions in 3 episodes 4 per episode

every mention, scene by scene, with the transcript →

Everything said about insitro, oldest first

May 19, 2023 neutral
Disclosure
Koller: Insitro uses agile for platform biology, but not drug discovery projects
“We have product managers who do scrums and do you know, these agile planning processes, and we apply that also to our platform development, even on the biology side. But at the same time, you know, drug discovery projects, which are years long, you don't do sc…”
Daphne Koller May 19, 2023 ▶ 38:28 No Priors Ep. 6 | With Daphne Koller from Insitro
May 19, 2023 bullish
Prediction Not checkable as stated
Koller: In three years new technologies may unlock more disease models
“Maybe in three years we'll have another tranche of diseases that are unlocked by the technological tidal wave that we're all riding.”
Daphne Koller May 19, 2023 ▶ 23:53 No Priors Ep. 6 | With Daphne Koller from Insitro
May 19, 2023
Disclosure
Koller: Insitro prioritizes single-cell diseases before complex organoid models
“There's plenty of things that we can do today where the where the disease does manifest sufficiently in a single cell lineage, and so we go after those first, and we defer some of the other ones to a later stage, because technologies such as organoids, for exa…”
Daphne Koller May 19, 2023 ▶ 23:03 No Priors Ep. 6 | With Daphne Koller from Insitro
May 19, 2023 positive
Insight
Koller: Partnering on existing drug assets can shave two to five years
“And that can usually say shave off, you know, two, three, maybe even five years from the development of a program because you've already made the drug. Sometimes you've already put it in people. You've shown that it's safe. You have a good biomarker for when i…”
Daphne Koller May 19, 2023 ▶ 26:13 No Priors Ep. 6 | With Daphne Koller from Insitro
May 19, 2023 bullish
Disclosure
Koller: Insitro aims to replace untranslatable animal models using human cellular models
“Which ultimately what we're looking to do is to replace the sort of untranslatable animal models with something that is much more driven from human biology.”
Daphne Koller May 19, 2023 ▶ 16:35 No Priors Ep. 6 | With Daphne Koller from Insitro
May 19, 2023 neutral
Disclosure
Koller: Insitro expands into metabolism and oncology due to standard-of-care data
“The other areas that we've gone into are metabolism and oncology, because again, those are areas where relevant, disease relevant data, That is high content, that is unbiased and truly informative about the disease state is collected quite abundantly as part o…”
Daphne Koller May 19, 2023 ▶ 21:04 No Priors Ep. 6 | With Daphne Koller from Insitro
Jan 11, 2024 positive
Insight
Koller: AI requires synthesizing deep learning with causal and interpretable modeling
“What I think we're starting to see right now is a the pendulum starting to swing back in the sense that there is a greater understanding that you really need a bit of both. You need that hugely powerful pattern recognition that we get from deep learning, but y…”
Daphne Koller Jan 11, 2024 ▶ 12:38 No Priors Ep. 46 | Best of 2023 with Sarah Guo and Elad Gil
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.